Shiro Suzuki
- Molecular Biology top 10%
- Reproductive Medicine top 1%
- Oncology top 5%
- Epidemiology top 5%
- Hepatology top 1%
- Co-authors
- Fumitaka KikkawaHiroaki KajiyamaKiyosumi ShibataKaoru NiimiNobuhisa YoshikawaM MuranakaSatoshi TamauchiTakuya Miyamoto
- Topics
- Ovarian cancer diagnosis and treatment (50 papers)Endometrial and Cervical Cancer Treatments (44 papers)Enzyme function and inhibition (19 papers)
- Journals
- ScienceJournal of Clinical OncologySHILAP Revista de lepidopterología
- Partner nations
- JapanUnited StatesAustralia
In The Last Decade
Shiro Suzuki
182 papers receiving 3.3k citations
Peers
Comparison fields: 5 of 131
- Molecular Biology 832
- Reproductive Medicine 753
- Oncology 683
- Epidemiology 622
- Hepatology 569
Countries citing papers authored by Shiro Suzuki
This map shows the geographic impact of Shiro Suzuki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiro Suzuki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiro Suzuki more than expected).
Fields of papers citing papers by Shiro Suzuki
This network shows the impact of papers produced by Shiro Suzuki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiro Suzuki. The network helps show where Shiro Suzuki may publish in the future.
Co-authorship network of co-authors of Shiro Suzuki
This figure shows the co-authorship network connecting the top 25 collaborators of Shiro Suzuki. A scholar is included among the top collaborators of Shiro Suzuki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiro Suzuki. Shiro Suzuki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 8 | |
| 4 | 1 | |
| 5 | 4 | |
| 6 | 2 | |
| 7 | 2 | |
| 8 | 9 | |
| 9 | 17 | |
| 10 | 24 | |
| 11 | 28 | |
| 12 | 18 | |
| 13 | 66 | |
| 14 | 52 | |
| 15 | 17 | |
| 16 | 59 | |
| 17 | 18 | |
| 18 | 132 | |
| 19 | 3 | |
| 20 | Liver Functions and Histology in HBV Carriers,with a Special Reference to Comparison with HBs Ag Negative Controls | 0 |
About Shiro Suzuki
Shiro Suzuki is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Hepatology, having authored 192 papers that have together received 3.4k indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (50 papers), Endometrial and Cervical Cancer Treatments (44 papers) and Enzyme function and inhibition (19 papers). The work is most often cited by research in Reproductive Medicine (753 citations), Hepatology (569 citations) and Obstetrics and Gynecology (449 citations). Shiro Suzuki has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Fumitaka Kikkawa, Hiroaki Kajiyama, Kiyosumi Shibata, Kaoru Niimi, Nobuhisa Yoshikawa, M Muranaka, Satoshi Tamauchi, Takuya Miyamoto, K Koizumi and Hiroshi Tokiwa. Their work appears in journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.